On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
Articles
Federal marijuana reform prospects bright – provided the Senate flips, Biden wins
Tuesday’s general election could have huge implications for federal marijuana reform, but the biggest business impacts hinge on whether the U.S. Senate flips to the Democrats and former Vice President Joe Biden wins the presidency.
Illinois Marijuana Stores Have Now Sold More Than Half A Billion Dollars Worth Of Cannabis Products, State Announces
For the sixth month in a row, Illinois has hit yet another marijuana sales record, and it has reached the key benchmark of half a billion dollars worth of legal cannabis products being purchased since the launch of the program at the beginning of this year.
Study Finds Cannabis Oil An Effective Treatment For Fibromyalgia
Researchers in Brazil have found that cannabis oil can be an effective treatment for patients with fibromyalgia, according to the results of a clinical trial completed recently.
MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD
This dosing study on LSD will be utilized as MindMed prepares for its Phase 2b clinical trial of LSD for anxiety.
MindMed Has $50 Million In The Bank As It Looks Ahead To NASDAQ Uplisting
With an industry-leading psychedelic drug R&D portfolio, MindMed has plenty of options to leverage its cash-on-hand to a higher share price.
Study: Medical Cannabis Helps Patients Reduce Harmful Drinking Habits
A study by Canadian researchers suggests that 43.5 percent of patients who began using medical cannabis to mitigate harmful alcohol habits were able to reduce the frequency of their alcohol use or quit entirely.
Missouri Cannabis Supply Chain Ready For Business
With the green light given for a cannabis testing laboratory to begin operations, Missouri’s medical marijuana program supply chain is now complete and will soon be serving patients.
Study Shows Cannabis is Becoming a Less Divisive Issue in the U.S.
If there’s one thing all Americans can agree on right now, it’s how divided we are on most of the major issues in the nation. However, despite this significant divide, there is another thing that both sides can apparently agree on: cannabis.
Oregon Psilocybin Ballot Measure Can Help Dying People Find Peace, Doctor Says In TV Ad
Oregon’s first-of-its-kind ballot measure to legalize psilocybin therapy has the potential to help ease mental suffering for terminally ill people, a medical doctor says in a new TV ad for the initiative.
MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines
With MindMed's latest financing, total cash reserves now stand at CAD$50.1 million.
State Of Montana Launches Online Hemp Marketplace To Connect Buyers And Sellers
Say you’re a Montana farmer who has planted acres of industrial hemp. As harvest nears, you’re looking to offload it. Where do you go to find a buyer?
Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development
Field Trip's new psychedelic molecule, FT-104, is showing similar efficacy to psychedelics like psilocybin -- but with shorter duration.
Study of Canadian Workers Shows No Link Between Cannabis Use And Workplace Injury
Workers in Canada who have toked up recently don’t appear to have faced any greater risk of a workplace injury than those who abstained, according to a new study out this week, suggesting that cannabis use isn’t necessarily linked to sloppiness on the job.
Nevada marijuana market regains footing after strict COVID-19 restrictions, fewer tourists
Nevada’s recreational marijuana sales have largely recovered, having slumped in the spring from some of the strictest coronavirus shutdown measures in the nation and dwindling numbers of tourists visiting Las Vegas.